Stool Samples Provide Marker for Bowel Disease
By LabMedica International staff writers Posted on 08 Apr 2014 |
Image: The SRI 8610C gas chromatograph (Photo courtesy of SRI Instruments).
A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created which is an ideal noninvasive testing method for the diagnosis of gastro-intestinal diseases.
The method works by analyzing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have up until recently been very hard to differentiate.
Scientists at the University of the West of England (Bristol, UK) obtained 182 stool samples from patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) between October 2010 and October 2011. IBS samples were obtained from patients with diarrhea predominant (IBS-D), constipation predominant (IBS-C), and the alternating between the two syndrome (IBS-A). IBD samples were obtained from patients with both ulcerative colitis (UC) and Crohn's disease (CD). Control samples were collected from healthy patients.
The test was based on the volatile organic compounds (VOCs) emitted from their stool samples, which act as a proxy for conditions in the gastrointestinal tract and provide a unique profile, or fingerprint, for the different bowel diseases. The investigators developed the method using an SRI 8610C gas chromatograph (SRI Instruments, Torrance, CA, USA) coupled to a metal oxide sensor system with pattern recognition software.
The results showed that patients with IBD could be distinguished from healthy controls with an accuracy of 79%. The method was able to distinguish IBD from IBS with an accuracy of 76%. Differentiating patients with IBS from healthy controls using VOCs appeared to be more difficult and could only be achieved with an accuracy of 54%. The reasons could be because IBS is a functional disorder as opposed to a structural disorder, so the changes in composition of VOCs in the stool samples would not be as great, producing a very similar pattern to healthy controls.
In conclusion, the authors stated that: “Our work has demonstrated that a low-cost device based on VOC analysis could be used to potentially diagnose, and differentiate, IBS and IBD at the point of care. We will continue to study fecal volatiles as a way of detecting IBS, IBD and other gastrointestinal conditions and continue to develop our techniques further. If we're able to produce results that exceed current commercial methods, then our technique could be added to the growing number of medical tests that use VOC analysis as a diagnostic tool.” The study was published on March 27, 2014, in the Journal of Breath Research.
Related Links:
University of the West of England
SRI Instruments
The method works by analyzing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have up until recently been very hard to differentiate.
Scientists at the University of the West of England (Bristol, UK) obtained 182 stool samples from patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) between October 2010 and October 2011. IBS samples were obtained from patients with diarrhea predominant (IBS-D), constipation predominant (IBS-C), and the alternating between the two syndrome (IBS-A). IBD samples were obtained from patients with both ulcerative colitis (UC) and Crohn's disease (CD). Control samples were collected from healthy patients.
The test was based on the volatile organic compounds (VOCs) emitted from their stool samples, which act as a proxy for conditions in the gastrointestinal tract and provide a unique profile, or fingerprint, for the different bowel diseases. The investigators developed the method using an SRI 8610C gas chromatograph (SRI Instruments, Torrance, CA, USA) coupled to a metal oxide sensor system with pattern recognition software.
The results showed that patients with IBD could be distinguished from healthy controls with an accuracy of 79%. The method was able to distinguish IBD from IBS with an accuracy of 76%. Differentiating patients with IBS from healthy controls using VOCs appeared to be more difficult and could only be achieved with an accuracy of 54%. The reasons could be because IBS is a functional disorder as opposed to a structural disorder, so the changes in composition of VOCs in the stool samples would not be as great, producing a very similar pattern to healthy controls.
In conclusion, the authors stated that: “Our work has demonstrated that a low-cost device based on VOC analysis could be used to potentially diagnose, and differentiate, IBS and IBD at the point of care. We will continue to study fecal volatiles as a way of detecting IBS, IBD and other gastrointestinal conditions and continue to develop our techniques further. If we're able to produce results that exceed current commercial methods, then our technique could be added to the growing number of medical tests that use VOC analysis as a diagnostic tool.” The study was published on March 27, 2014, in the Journal of Breath Research.
Related Links:
University of the West of England
SRI Instruments
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines